Frontlight ResearchEarly access
Active, not recruitingNo phase
Mirror Medacta Shoulder System Pivotal Trial
Key facts
- Who runs it
- Medacta International SA
- Where
- Switzerland2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people, planned
- Started
- 5 Jan 2022
- Expected to end
- 28 Feb 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mirror Medacta Shoulder System
- Medacta Shoulder System
- Record updated
- 7 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (21)Hide the full registry criteria
Who can take part
- Age ≥ 18 yr
- Clinical indication for anatomic primary total shoulder replacement due to osteoarthritis and/or posttraumatic arthritis
- Willingness and ability to comply with study protocol
Who cannot take part
- Prior rotator cuff surgery
- Insufficient bone quality which may affect the stability of the implant
- Chemotherapy treatment/radiotherapy within 6 mo before surgery
- >5 mg/day of corticosteroids, excluding inhalers, within 3 years before surgery
- Alcohol or drug abuse
- Previous or current infection at or near the site of implantation
- Medical condition or balance impairment that could lead to falls
- Active metastatic or neoplastic disease at the shoulder joint
- Inability to understand study or a history of noncompliance with medical advice
- Metal allergies or sensitivity
- Current distant or systemic infection
- ONLY for women of childbearing age: a positive pregnancy test (urine / blood)
- Cuff tear arthropathy/insufficient rotator cuff
- Neuromuscular compromise of shoulder or other disabilities affecting the maximum functional outcomes
- Weight bearing shoulder due to wheel chair, crutches, rollator at the time of operation
- Pregnancy or plan to become pregnant during study period
- Current enrollment in any clinical research study that might interfere with this study
- Patient, whose infomed consent form should be taken in an emergency situation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.
The 2 groups in the trial
- Mirror groupTreatment being tested
Mirror Medacta Shoulder System
Treatment: Mirror Medacta Shoulder System
- Historical Control groupExisting treatment, for comparison
Total shoulder arthroplasty system
Treatment: Medacta Shoulder System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multicentric, Prospective, Comparative Trial to Assess the Efficacy and Safety of an Anatomic Total Shoulder System.
- Record updated
- 7 October 2026